Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P326: Physicians’ recommendations for travel in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

W.P.W. Chan1,2, H.H. Shim2, S.C. Ng3, Asia–Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group, J. Liu1, C. Inglis1, K. Greveson4, R.W. Leong1*

1Concord Repatriation General Hospital, Department of Gastroenterology, Sydney, Australia, 2Singapore General Hospital, Gastroenterology, Singapore, Singapore, 3Institute of Digestive Disease, The Chinese University of Hong Kong, Department of Medicine, Hong Kong, Hong Kong, 4Royal Free Hospital, London, UK

P327: Symptom relevance attributed by inflammatory bowel disease patients has a differential impact on their quality of lifeECCO '18 Vienna
Year: 2018
Authors:

F. Casellas*, C. Herrera de Guise, V. Robles, E. Navarro, M. Guirola, N. Borruel

Hospital Universitari Vall Hebron, Barcelona, Spain, Barcelona, Spain

P328: Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)ECCO '18 Vienna
Year: 2018
Authors:

K. Krishnaprasad1,2*, A. Walsh3, J. Begun4, S. Bell2, D. Carter5, R. Grafton6, A. Sechi7, K. Sewell8, A. McMahon8, S. Connor7, G. Radford-Smith1,8,9, J. Andrews6,10, ANZIBD Consortium, Crohn's Colitis Cure

1QIMR Berghofer Medical Research Institute, Inflammatory Bowel Diseases Research Group, Herston, Australia, 2St. Vincent's Hospital Melbourne, Department of Gastroenterology and Hepatology, Melbourne, Australia, 3St. Vincent's Hospital Sydney, Department of Gastroenterology and Hepatology, Sydney, Australia, 4Mater Hospital, Department of Gastroenterology, Brisbane, Australia, 5Stratos Technology Partners, Christchurch, New Zealand, 6Royal Adelaide Hospital, Department of Gastroenterology and Hepatology, Adelaide, Australia, 7Liverpool Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia, 8Royal Brisbane and Women’s Hospital, Department of Gastroenterology and Hepatology, Brisbane, Australia, 9University of Queensland, School of Medicine, Brisbane, Australia, 10University of Adelaide, School of Medicine, Adelaide, Australia

P329: Utility of faecal calprotectin to assess Crohn’s disease activity in patients with an ileostomyECCO '18 Vienna
Year: 2018
Authors:

C.R. Rowan1*, S. Alzubi2, M. Healy3, G. Cullen4, H. Mulcahy4, J. Sheridan3,4, G.A. Doherty4

1St.Vincent's University Hospital, Gastroenterology, Dublin, Ireland, 2St.Vincent's University Hospital, Center for Colorectal Disease, Dublin, Ireland, 3University College Dublin, School of Medicine, Dublin, Ireland, 4St Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland

P330: A prospective trial to evaluate the feasibility of a mobile app in patients with inflammatory bowel disease under maintenance therapyECCO '18 Vienna
Year: 2018
Authors:

S. Coenen1*, E. Weyts1, P. Geens1, E. Nijns2, R. Van Durm2, M. Ferrante1, S. Vermeire1, B. Van den Bosch2, G. Van Assche1

1UZ Leuven, Gastroenterology and Hepatology, Leuven, Belgium, 2UZ Leuven, Information Technology, Leuven, Belgium

P331: Development of a novel transabdominal ultrasound disease activity score in patients with ulcerative colitis (UCUS score)ECCO '18 Vienna
Year: 2018
Authors:

Y. Hashimoto1*, N. Kume1, K. Sato1, T. Kanemura1, A. Haga1, Y. Ishii1, M. Nishio1, H. Otake1, N. Takahashi1, T. Ogashiwa1, M. Izumi2, A. Hanzawa2, H. Yonezawa2, Y. Saigusa3, S. Maeda4, H. Kimura1, R. Kunisaki1

1Yokohama City University Medical Centre, Inflammatory Bowel Disease Centre, Yokohama, Japan, 2Yokohama City University Medical Centre, Department of Laboratory Medicine and Clinical Investigation, Yokohama, Japan, 3Yokohama City University, Department of Biostatistics, Yokohama, Japan, 4Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan

P332: A treat-to target strategy guided by pan-enteric valuation in paediatric Crohn’s disease improves outcomes at 2 yearsECCO '18 Vienna
Year: 2018
Authors:

S. Oliva1*, S. Cohen2, M. Aloi1, S. Mallardo1, F. Viola1, G. D'Arcangelo1, F. Maccioni3, C. Hassan4, P. Papoff5, S. Cucchiara1

1Sapienza - University of Rome, Department of Pediatrics, Pediatric Gastroenterology and Liver Unit, Rome, Italy, 2Children's Center for Digestive Health Care, Atlanta, USA, 3Sapienza – University of Rome, Department of Radiological Sciences, Oncology, and Pathology, Rome, Italy, 4Nuovo Regina Margherita Hospital, Gastroenterology Department, Rome, Italy, 5Sapienza – University of Rome, Department of Pediatrics PICU, Rome, Italy

P333: The baseline features of patients with newly diagnosed moderate-to-severe ulcerative colitis in Korea: A population-based cohort study (the MOSAIK cohort)ECCO '18 Vienna
Year: 2018
Authors:

S.J. Oh1*, J.R. Moon1, C.K. Lee1, Y.M. Park1, S.N. Hong2, J.P. Im3, B.D. Ye4, J.M. Cha1, S.-A. Jung5, K.-M. Lee6, D.I. Park7, Y.T. Jeen8, Y.S. Park9, J.H. Cheon10, H.-S. Kim11, Y. Kim11, H.J. Kim1, H.J. Kim1, the IBD research group of the Korean Association for the Study of Intestinal Diseases

1Kyung Hee University School of Medicine, Seoul, South Korea, 2Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Seoul National University College of Medicine, Seoul, South Korea, 4University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 5Ewha Womans University School of Medicine, Seoul, South Korea, 6St. Vincent’s Hospital, The Catholic University of Korea, Seoul, South Korea, 7Department of Internal Medicine Kangbuk Samsung Hospital Sungkyunkwan University, Seoul, South Korea, 8Korea University College of Medicine, Seoul, South Korea, 9Eulji University College of Medicine, Seoul, South Korea, 10Yonsei University College of Medicine, Seoul, South Korea, 11Medical affairs, Janssen Korea, Seoul, South Korea

P334: Does the circadian clock have a role in the pathogenesis of inflammatory bowel disease (IBD)?ECCO '18 Vienna
Year: 2018
Authors:

Y. Weintraub1*, S. Cohen1, I. Dotan2,3, R. Tauman3,4, N. Chapnik5, O. Froy5

1"Dana-Dwek" Children's Hospital, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, The Pediatric Gastroenterology unit, Tel Aviv, Israel, 2Rabin Medical Center, Division of Gastroenterology, Petach Tikvah, Israel, 3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 4"Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Pediatric Sleep Center, Tel Aviv, Israel, 5The Hebrew University, Institute of Biochemistry, Food Science and Nutrition, Faculty of Agriculture, Food and Environment, Rehovot, Israel

P335: A prospective multicentre “real-life” international validation study of the PICaSSO endoscopic scoring system against histologic scoring system to define mucosal healing in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

M. Iacucci1,2*, M. Lazarev3, G.E. Tontini4, M. Daperno5, M. Goetz6, X. Gui7, V. Villanacci8, B.C. Lethebe9, M. Vecchi4, G. De Hertogh10, R. Mannan11, R. Hejmadi12, S. Smith2, U. Shivagi2, P. Bhandari13, S. Ghosh2, R. Kiesslich14, R. Bisschops15

1University of Calgary, Gastroenterology, Calgary, Canada, 2Institute of Translational of Medicine, University of Birmingham, Birmingham, UK, 3Division of Gastroenterology, Baltimore, USA, 4Division of Gastroenterology IRCCS Policlinico San Donato, Milan, Italy, 5Division of Gastroenterology, Torino, Italy, 6Division of Gastroenterology, University Klinikum Tuebingen, Tuebingen, Germany, 7University of Calgary, Pathology, Calgary, Canada, 8Institute of Pathology ASST Ospedali Civili, Brescia, Italy, 9University of Calgary, Calgary, Canada, 10University of Leuven, Leuven, Belgium, 11University John Hopkins, Baltimore, USA, 12University of Birmingham, Birmingham, UK, 13University of Portsmouth, Portsmouth, UK, 14Director of Internal Medicine II, HSK Hospital, Wiesbaden, Germany, 15Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium

P336: Is endoscopy necessary to measure disease activity in ulcerative colitis: A systematic narrative reviewECCO '18 Vienna
Year: 2018
Authors:

S. Restellini1,2*, C.-Y. Chao1,3, O. Kherad4, M. Martel5, A.N. Barkun1, E. Seidman1, G. Wild1, A. Bitton1, W. Afif1, T. Bessissow1, P.L. Lakatos1,6

1McGill University Health Centre, Gastroenterology, Montreal, Canada, 2Division of Gastroenterology and Hepatology, Department of Medical Specialties, Geneva, Switzerland, 3Princess Alexandra Hospital, Department of Gastroenterology and Hepatology, Brisbane, Australia, 4La Tour Hospital and University of Geneva, Internal Medicine Department, Geneva, Switzerland, 5McGill University Health Center, Division of Gastroenterology, Epidemiology and Biostatistics and Occupational Health, Montreal, Canada, 6Semmelweis University, 1st Department of Medicine, Budapest, Hungary

P337: Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patientsECCO '18 Vienna
Year: 2018
Authors:

L. Biedermann on behalf of the Swiss IBD Cohort Study Group1*, F. Wüstholz2, N. Fournier3, T. Greuter2, P. Schreiner2, B. Misselwitz2, J. Zeitz4, M. Scharl2, P. Frei5, E. Safroneeva6, A. Schoepfer7, M. Kaelin8, G. Rogler2, S.R. Vavricka9

1University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 2University Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland, 3University of Lausanne, IUMSP, Lausanne, Switzerland, 4Klinik Hirslanden, Department of Gastroenterology, Zurich, Switzerland, 5Clinic Bethanien, Division of Gastroenterology and Hepatology, Zurich, Switzerland, 6University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 7University Hospital Lausanne, Division of Gastroenterology and Hepatology, Lausanne, Switzerland, 8Unilabs Switzerland, Medical Diagnostics, Duebendorf, Switzerland, 9Center of Gastroenterology and Hepatology, Zurich, Switzerland

P338: Outcome of hospitalised patients with inflammatory bowel disease complicated by Clostridium difficile infection: Results from a tertiary referral centreECCO '18 Vienna
Year: 2018
Authors:

O. Stoica1*, C. Stanciu2, A.-M. Singeap3, I. Girleanu3, S. Chiriac1, C. Muzica1, A. Trifan3

1"Gr. T. Popa" University of Medicine and Pharmacy, Iasi, Romania, 2Institute of Gastroenterology and Hepatology, Bd. Independentei, no. 1, Gastroenterology and Hepatology, Iasi, Romania, 3"Gr. T. Popa" University of Medicine and Pharmacy, Institute of Gastroenterology and Hepatology, Iasi, Romania

P339: Crohn’s disease and self-monitoring through a mobile App: The Medicrohn studyECCO '18 Vienna
Year: 2018
Authors:

A. Echarri1*, I. Vera2, J. Guardiola3, R. De Lucas2, V. Ollero1, B. Castro4, F. Gallego5, M. Aguas6, M. Chaparro7, C. Arajol3, P. Robledo8, D. Ceballos9, S. García10, S. Riestra11, I. Marín-Jimenez12, J. Muñiz13, P. Nos6

1Complejo Hospitalario Ferrol, Gastroenterology, Ferrol, Spain, 2Hospital Universitario Puerta De Hierro, Madrid, Spain, 3Hospital Universitari de Bellvitge, Barcelona, Spain, 4Hospital Marques de Valdecilla, Santander, Spain, 5Hospital de Poniente, Almería, Spain, 6Hospital Universitario La Fe, Valencia, Spain, 7Hospital Universitario de La Princesa, Madrid, Spain, 8Hospital San Pedro De Alcantara, Caceres, Spain, 9Hospital Doctor Negrín, Gran Canaria, Spain, 10Hospital Miguel Servet, Zaragoza, Spain, 11Hospital Central de Asturias, Oviedo, Spain, 12Hospital General Universitario Gregorio Marañón, Madrid, Spain, 13Universidad de La Coruña, Coruña, Spain

P340: Serum albumin and C-reactive protein week 2/week 0 ratio after anti-TNF therapy best predict both short- and long-term clinical outcomes in anti-TNF-naïve ulcerative colitis patientsECCO '18 Vienna
Year: 2018
Authors:

S.-H. Lee1*, K. Chang1, E.M. Song1, S.W. Hwang1,2, S.H. Park1,2, D.-H. Yang1, J.-S. Byeon1, S.-J. Myung1, S.-K. Yang1,2, B.D. Ye1,2

1University of Ulsan College of Medicine, Asan Medical Center, Department of Gastroenterology, Seoul, South Korea, 2University of Ulsan College of Medicine, Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea

P341: Faecal biomarkers compared with MRI using the MaRIA and Clermont scores for monitoring inflammatory activity in patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Langhorst1*, A. Koch1, J. Boone2, A. Rueffer3, G. Dobos4, L. Umutlu5, Y. Li5

1University of Duisburg-Essen, Integrative Gastroenterology, Kliniken Essen-Mitte, Essen, Germany, 2Tech Lab Inc., Blacksburg, USA, 3Labor L+S, Enterosan, Bad Bocklet-Grossenbrach, Germany, 4University of Duisburg-Essen, Integrative and Internal Medicine, Essen, Germany, 5University Hospital Essen, Institute of Diagnostic and Interventional Radiology and Neuroradiology, Essen, Germany

P342: Development of self-screening tool for perianal disease in patients with Crohn’s disease: A pilot studyECCO '18 Vienna
Year: 2018
Authors:

E.S. Kim1, B.I. Jang2*, H.S. Lee1, Y.J. Lee3, E.Y. Kim4, K.O. Kim2, K.H. Song5, S.K. Kim1, Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)

1Kyungpook National University School of Medicine, Internal Medicine, Daegu, South Korea, 2Yeungnam University College of Medicine, Department of Internal Medicine, Daegu, South Korea, 3Keimyung University School Of Medicine, Department of Internal Medicine, Daegu, South Korea, 4Catholic University of Daegu, Department of Internal Medicine, Daegu, South Korea, 5Goo Hospital, Department of Surgery, Daegu, South Korea

P343: Levels of the anticoagulant and anti-inflammatory protein S (PROS1) in patients with inflammatory bowel disease (IBD) relationship with disease activity, IBD disease patterns, and C4-binding protein (C4BP)ECCO '18 Vienna
Year: 2018
Authors:

A. Sambuelli1*, P. Chavero1, G. de Larrañaga2, A. Errasti3, S. Peres2, L. Tessone3, S. Negreira2, N. Silvia1, M. Bellicoso1, S. Huernos1, S. Goncalves1, P. Tirado1, E.A. Carrera Silva4, C. Rothlin5

1Hospital Bonorino Udaondo, IBD Section - Medicine, Buenos Aires, Argentina, 2Hospital of Infectious Diseases F. J. Muñiz, Hemostasis and Thrombosis Laboratory, Buenos Aires, Argentina, 3Instituto de Farmacología, Facultad de Medicina Universidad de Buenos Aires, Buenos Aires, Argentina, 4Instituto de Medicina Experimental (IMEX), Academia Nacional de Medicina, Buenos Aires, Argentina, 5Yale University School of Medicine, Department of Immunobiology and Pharmacology, New Haven, USA

P344: Epidemiology of clostridium difficile infections in IBD over two decadesECCO '18 Vienna
Year: 2018
Authors:

A. Moens1,2*, B. Verstockt1,2, K. Machiels2, P. Bossuyt3, A. Verdonck4, K. Lagrou4, S. Vermeire1,2, M. Ferrante1,2

1University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 2KU Leuven, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium, 3Imeldaziekenhuis, Department of Gastroenterology and Hepatology, Bonheiden, Belgium, 4University Hospitals Leuven, Department of Laboratory Medicine, Leuven, Belgium

P345: Impact of aphthous colitis at diagnosis on Crohn’s disease outcomesECCO '18 Vienna
Year: 2018
Authors:

C. Delattre1*, I. Nion-Larmurier1, A. Bourrier1, C. Landman1, G. Le Gall2, J. Kirchgesner1, H. Sokol1, L. Beaugerie1, J. Cosnes1, P. Seksik1

1APHP Hôpital Saint Antoine, Gastro-entérologie et Nutrition, Paris, France, 2Hôpital Begin, Gastro-entérologie, Saint-Mandé, France